Tumors were subsequently classified by flow cytometry as either pre-B cell (IgM−), immature B cell (IgM+), mixed (IgM+/−) or as early hematopoietic progenitor-derived lymphomas (B220+CD4+). Here, CD4 is linked to lymphoma.